Overview

Donepezil in the Prevention of Post-Operative Cognitive Decline

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility of using Donepezil to prevent post-operative cognitive decline (POCD) among individuals aged 65 and older who have a baseline mild cognitive impairment (MCI) and are undergoing elective hip or knee replacement.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Donepezil